Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of IPO4 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of IPO4 mRNA | affects expression | 21346803
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of IPO4 mRNA | decreases expression | 18648102
|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of IPO4 mRNA | affects expression | 21346803
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of IPO4 mRNA | affects expression | 17562736
|
D000082 |
Acetaminophen |
Acetaminophen results in increased expression of IPO4 mRNA | increases expression | 19420014
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of IPO4 mRNA | increases expression | 17989879
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of IPO4 mRNA | increases expression | 15336504
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of IPO4 mRNA | increases expression | 20106945
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of IPO4 mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of IPO4 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of IPO4 mRNA | affects cotreatment|increases expression | 17942748
|
D009532 |
Nickel |
MT1 affects the reaction [Nickel affects the expression of IPO4 mRNA] | affects expression|affects reaction | 16166738
|
D009532 |
Nickel |
MT2 affects the reaction [Nickel affects the expression of IPO4 mRNA] | affects expression|affects reaction | 16166738
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of IPO4 mRNA | affects binding|increases activity|increases expression | 19710929
|
D011374 |
Progesterone |
Progesterone results in decreased expression of IPO4 mRNA | decreases expression | 18037150
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of IPO4 mRNA | affects expression | 17555576
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of IPO4 mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of IPO4 mRNA | increases expression | 18796159 17942748
|
D014635 |
Valproic Acid |
Valproic Acid results in decreased expression of IPO4 mRNA | decreases expression | 19101580
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.61 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
14.58 | 7525203 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
14.58 | 11752688 15322242 14514962 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
14.58 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.96 | 19490988 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.00 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
Nickel |
9.35 | 16166738 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
9.35 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.82 | 14692618 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
2.77 | 3712494 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
10.07 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.07 | 16835633 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.30 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.97 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.91 | 10982225 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.59 | 17497229 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.51 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.68 | 15885639 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.85 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.85 | 18316065 17157402 17507914 18396377 18558336 19232924 20603192 18177632 18985861 16609825 15238991 18775368 18940202 17688650 19460635 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
5.08 | 11289319 1440618 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.09 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.86 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.86 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.85 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
8.08 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
8.08 | 8888407 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.89 | 11985600 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.40 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.30 | 15845082 15665606 15380490 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
2.36 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Nickel |
2.36 | 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.36 | 15562024 17614352 16175315 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
2.36 | 17893378 19066611 18815881 21152245 19189210 19244106 20135344 19410462 19189212 21138602 15668708 17261762 19142967 20005174 19115204 16273361 19084267 18425577 20544844 16873071 16202921 17440819 11161223 20859285 19155303 18997820 19011961 17049068 18351453 19487384 19221464 19288272 15565566 20065188 18855134 17242785 19289846 18984771 18821012 19200415 18629630 16818667 19103187 20390343 19059307 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.36 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.82 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.55 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
8.91 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
8.91 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
8.91 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
8.91 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
8.91 | 16924424 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.04 | 17123778 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.69 | 7296757 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.64 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.38 | 18850075 18670907 16120746 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
7.47 | 14694615 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
7.47 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
11.25 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
11.25 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
11.25 | 12371664 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.72 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.19 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
19.39 | 9022650 19486331 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
19.39 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
19.39 | 16105132 11677210 16919318 17333356 17681005 15861022 17110522 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
19.39 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.11 | 15340226 16354765 8697196 15668235 12621046 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
9.27 | 15095906 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
9.27 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.48 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
2.48 | 17688650 16575769 8888407 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
11.04 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
11.04 | 18551238 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.40 | 19031437 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
7.38 | 18759878 11906362 12868966 2524372 11298694 14531868 8970840 8156756 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Nickel |
7.38 | 19470301 17244072 17100760 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.44 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
9.65 | 2952479 3621924 |
MESH:D003877 |
Dermatitis, Contact |
|
Nickel |
9.65 | 2952479 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.67 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.50 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.53 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
18.84 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
18.84 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
18.84 | 18289764 6482804 18692083 9328219 9653073 1440618 8291058 16192314 18648102 7440962 9022650 6679447 11289319 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
18.84 | 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
18.84 | 15968718 16109766 17522070 16227642 11421492 17906064 11529661 11461765 10663392 16177239 11739529 16781746 10774834 10915739 16393943 16081117 11743745 11287661 19164858 19739265 19923254 18071297 18713872 12705907 12153990 19085960 12594235 19416960 12540782 14725611 15619225 11834606 2444490 12958197 12392966 14986274 19370779 19420014 16485898 17562736 14550746 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
18.84 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
18.84 | 1733752 19641884 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.16 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.78 | 11462148 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.08 | 1851702 |
MESH:D004487 |
Edema |
|
pirinixic acid |
6.63 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.63 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.96 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
15.55 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
15.55 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
15.55 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
3.06 | 16202921 20544844 19155303 17893378 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
9.02 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
9.02 | 9294722 10568697 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.19 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.98 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.95 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.61 | 7562514 6426943 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.34 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.11 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.11 | 3581430 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.03 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
24.98 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
24.98 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
24.98 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
24.98 | 14986274 19224547 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
24.98 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.25 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.50 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.95 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.17 | 8888407 18558336 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
5.08 | 6705139 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.58 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.23 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.62 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.62 | 20067830 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.74 | 16983495 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.27 | 8708960 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
4.07 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.66 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.34 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.55 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.47 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.36 | 11000095 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.55 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.40 | 16221962 19176532 18467677 19772884 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.40 | 15340226 16120746 12621046 |
MESH:D015658 |
HIV Infections |
|
Nickel |
3.83 | 17263646 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.92 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.11 | 8697196 18606429 15340226 16959395 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.72 | 16870215 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.21 | 20558911 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.98 | 15034207 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.98 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.98 | 18670907 18850075 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.85 | 16569931 16945680 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.44 | 15869954 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.49 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.50 | 17937319 |
MESH:D007249 |
Inflammation |
|
Nickel |
12.13 | 16166738 |
MESH:D007249 |
Inflammation |
|
Progesterone |
12.13 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
12.13 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
12.13 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
7.37 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.37 | 16306350 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
5.08 | 8074119 9022650 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.36 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.50 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
5.85 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
5.85 | 18776723 10903974 8314463 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
23.60 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
23.60 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
23.60 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
23.60 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
23.60 | 18625569 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.15 | 16294345 17596541 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.17 | 15342952 17567588 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.21 | 9327722 15034207 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.40 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
3.40 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.40 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.63 | 19784758 16610002 19460945 12587719 19014921 11587558 12969438 16611625 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.26 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
10.75 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
10.75 | 16377806 20007298 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
10.75 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
10.75 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
9.87 | 2876784 6135515 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
9.87 | 598648 1399818 6587162 3712494 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
9.87 | 12151625 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.32 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
2.25 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.25 | 19555203 11884234 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.81 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
6.14 | 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
6.14 | 11731420 19196723 14580682 16827153 19196722 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.61 | 19453300 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
1.88 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.23 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.61 | 19513568 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.85 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.21 | 18765137 18803445 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.55 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.06 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.17 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.15 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.04 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.97 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
10.52 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
10.52 | 7678174 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
5.73 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
5.73 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.52 | 19410462 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
1.96 | 17405874 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.06 | 19189210 19200415 19196722 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.50 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.31 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
9.71 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.71 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
7.31 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
7.31 | 16359493 8888407 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.89 | 18514411 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.82 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
21.83 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
21.83 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
21.83 | 4026338 6482804 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
21.83 | 14694615 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
5.08 | 3988306 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.04 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
2.53 | 17393432 16525653 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.41 | 16870215 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.72 | 11578682 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.52 | 7296757 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.31 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.53 | 6228378 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.59 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.25 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
16.56 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
16.56 | 11399792 11896295 11222880 11118676 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
16.56 | 20603192 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.24 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
3.29 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
3.29 | 15067354 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.36 | 15861022 16919318 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.60 | 12752131 11422049 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.24 | 16882103 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.84 | 10548101 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.40 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.87 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.39 | 3692021 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.21 | 19155313 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.86 | 18045962 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.07 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
9.93 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
9.93 | 18551238 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
9.93 | 11738929 14763951 16876388 3137016 17978042 11044598 15475178 1511512 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
5.63 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.63 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
11.77 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
11.77 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
11.04 | 16503802 15862959 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
11.04 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.80 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.60 | 12833885 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.03 | 16684133 16045194 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.65 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.18 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.96 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.90 | 3712494 6582329 7505956 6587162 1399818 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.30 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.57 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
12.00 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
12.00 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
12.00 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
12.00 | 17572228 16712894 8653321 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.68 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
12.16 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
12.16 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.01 | 10982225 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.07 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.33 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.05 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.66 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.57 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.31 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.50 | 17120751 |